
China BlueChemical Ltd., together with its subsidiaries, develops, manufactures, and sells mineral fertilizers and chemical products in the People's Republic of China and internationally. The company operates through Urea, Phosphorus and Compound Fertiliser, Methanol, and Others segments. It offers urea; mono-ammonium phosphate, di-ammonium phosphate, and compound fertilizers; methanol; and bulk blending fertilizers, and polyformaldehyde and woven plastic bags. The company is also involved in the trading of fertilizers and chemicals; mining, processing, manufacturing, and selling of phosphate; port operations; and provision of preparatory work for methanol and dimethyl-ether projects. In addition, it offers transportation and overseas shipping services; and manufactures and sells acrylonitrile and methyl methacrylate. The company was formerly known as CNOOC Chemical Limited and changed its name to China BlueChemical Ltd. in April 2006. The company was founded in 2000 and is headquartered in Beijing, the People's Republic of China. China BlueChemical Ltd. is a subsidiary of China National Offshore Oil Corporation.
China BlueChemical Ltd. trades as CBLUF on OTC. The company is classified in Basic Materials / Agricultural Inputs and reports in USD.
The current profile places the business in Agricultural Inputs. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Latest available fiscal data shows $11.72B of revenue and $949.29M of net income.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
China BlueChemical Ltd. can be compared against peers such as AlzChem Group AG, China Resources Cement Holdings Limited, Denka Company Limited, Iluka Resources Limited, Iluka Resources Limited, Kaneka Corporation.
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $1.52B, beta of 0.81, and return on equity of +5.0%.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
CBLUF currently shows total debt of $2.11B and beta of 0.81. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.chinabluechem.com.cn
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.